Recent Finacing
Recent Raise
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company developing targeted radiopharmaceuticals using proprietary molecule-design technologies, operating Vancouver research facilities, partnering with isotope suppliers and CDMOs, and advancing assets to human studies.
Recent Investors
Total Raised
Funding round
Investors